Literature DB >> 8785132

Metabolic and hormonal responses to induced hypotension for middle ear surgery.

M C Newton1, G D Chadd, B O'Donoghue, S M Sapsed-Byrne, G M Hall.   

Abstract

We have investigated in 30 patients the metabolic and hormonal responses to middle ear surgery using induced hypotension to a mean arterial pressure of 55 mm Hg. A standardized anaesthetic technique of propranolol, thiopentone-vecuronium-isoflurane was used in all patients and hypotension induced with sodium nitroprusside, trimetaphan camsylate or additional isoflurane. All patients showed a classic stress response with an increase in circulating blood glucose, cortisol and growth hormone concentrations. Blood lactate and plasma uric acid concentrations changed little during operation, suggesting that tissue oxygenation was adequate. However, the former declined after operation, possibly as a result of the concomitant use of propranolol. There were no significant differences between the three hypotensive techniques in their effects on the hormonal and metabolic response, although the increase in blood glucose concentration in the trimetaphan group was obtunded. We conclude that induced hypotension for middle ear surgery induced an endocrine and metabolic response of small magnitude and short duration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8785132     DOI: 10.1093/bja/76.3.352

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  A Comparison of the Effects of Esmolol and Dexmedetomidine on the Clinical Course and Cost for Controlled Hypotensive Anaesthesia.

Authors:  Zeynel Abidin Erbesler; Nurten Bakan; Gülşah Yılmaz Karaören; Muhammet Ali Erkmen
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-05-23

2.  Comparison of surgical conditions in 2 different anesthesia techniques of esmolol-induced controlled hypotension in breast reduction surgery.

Authors:  Ahmet Besir; Bahanur Cekic; Dilek Kutanis; Ali Akdogan; Murat Livaoglu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.